Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afuresertib plus weekly paclitaxel vs weekly paclitaxel in platinum-resistant ovarian cancer
CTR20202361Phase 2Completed
- Sponsor
- Laekna
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afuresertib, paclitaxel in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Laekna. Started Nov 2020; status: completed.
02
Drugs
afuresertibpaclitaxel
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on CTR20202361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202361.